Apellis Pharmaceuticals EPS Diluted (TTM) Analysis

Apellis Pharmaceuticals Inc (APLS)

46.71 -0.80 (-1.68%) USD | NASDAQ | Apr 19, 13:01

EPS Diluted (TTM) Chart

Historical EPS Diluted (TTM) Data

View and export this data back to 2015. Upgrade now.

Date	Value
December 31, 2023	-4.48
September 30, 2023	-5.25
June 30, 2023	-5.83
March 31, 2023	-6.27
December 31, 2022	-6.13
September 30, 2022	-6.16
June 30, 2022	-6.69
March 31, 2022	-7.95
December 31, 2021	-8.85
September 30, 2021	-6.26
June 30, 2021	-5.77
March 31, 2021	-4.62
December 31, 2020	-4.59
September 30, 2020	-7.76
June 30, 2020	-7.07
March 31, 2020	-6.62

Date	Value
December 31, 2019	-5.20
September 30, 2019	-3.74
June 30, 2019	-3.28
March 31, 2019	-2.77
December 31, 2018	-2.33
September 30, 2018	-2.043
June 30, 2018	-1.703
March 31, 2018	-1.763
December 31, 2017	-1.833
September 30, 2017	-1.837
June 30, 2017	-1.935
March 31, 2017	-1.719
December 31, 2016	-2.942
September 30, 2016	-2.725
December 31, 2015	-2.463

Earnings per Share Definition

Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.

Read full definition.

EPS Diluted (TTM) Range, Past 5 Years

-8.85

Minimum

Dec 2021

-3.28

Maximum

Jun 2019

-5.922

Average

-6.13

Median

Dec 2022

EPS Diluted (TTM) Benchmarks